CVS HEALTH (CVS)
NYSE Market Closed
CVS Health Corporation is a large US healthcare group that combines retail pharmacies, prescription drug benefits, insurance, and care delivery under one corporate structure. Its best-known business is the CVS Pharmacy chain, which operates roughly 9,000 locations, mainly in the United States, and gives the company a broad consumer-facing presence in prescription dispensing, over-the-counter health products, vaccinations, and basic healthcare services.
The company’s reach extends well beyond its stores. Through Caremark, CVS operates one of the largest pharmacy benefit managers in the country, administering drug plans for employers, insurers, government programmes, and other clients. That business processes about 2 billion adjusted claims a year and plays a central role in formulary management, pharmacy networks, specialty drugs, and drug cost negotiation.
CVS also owns Aetna, a major health insurer serving about 27 million medical members. This gives the company exposure to commercial, Medicare, Medicaid, and other health plan markets. The addition of Oak Street Health expands CVS into value-based primary care, particularly for older patients, while other care assets support home-based and clinical services.
The investment case for CVS centres on whether it can use this integrated model to lower healthcare costs, improve patient engagement, and capture more spending across the healthcare chain. Its scale is a major advantage, but the company also operates in highly regulated and competitive markets where reimbursement pressure, drug pricing scrutiny, and execution across multiple business lines remain important factors.
Last updated
- Market Cap
- 122.4B
- P/E
- 41.75
- P/FCF
- 16.55
- P/S
- 0.3
- Enterprise Value
- 175.97B
- Sector
- —
- Industry
- Drug Stores and Proprietary Stores
- Address
- ONE CVS DR., WOONSOCKET, RI, 02895
H1 Receives $40M Investment in Round Led by CVS Health Ventures
NATPAT Launches Into CVS Nationwide in Brand's Largest U.S. Retail Expansion
Bioliberty Raises $10.2 million to Build Functional Intelligence Capabilities for Post‑Acute Care
Salvation Army Relocates to Woodbridge Shopping Center, Reaffirming Long-Term Commitment to the Woodbridge Corridor
$81.32 Bn Clinical Analytics Markets: Analysis by Offering, Source, Use Case, End User - Global Forecast to 2030: Rapid Digital Health Adoption and Real-Time Data Streams Accelerate Investments
Saggio Realty Announces Milestone Linked to Sale of Marco Island’s CVS-Anchored Plaza
Humana Stock Down as Medicare Rate Proposal Hits Insurers
CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm
E-Pharmacy Market Set to Quadruple, Reaching USD 435.82 Billion by 2034, Reports Towards Healthcare
The Korean Trio Shines Out at ECRM for Its Detoxifying Nutraceuticals
Thousands of State of Georgia employees walk 880 million steps to benefit Title I schools
Attention CIOs It Is Just One Week Away – Register Now! Florida C-suite executives invited to HMG Strategy’s 5th Annual C-Level Technology Leadership Summit on September 4
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Managed Healthcare Executive® announces 2025 PBMI Innovators Award winners
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 122.4B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 175.97B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 41.75
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.58
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.3
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 12.6
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.43
- EPS
- 2.3
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 2.78%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 16.55
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 11.85
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 7.39B
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 3.79%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 1.16%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.81
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.87
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.66
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.11
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 8.45M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 95.93
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 99.85B | 105.1B | 102.24B | 98.43B | 94.07B |
| Gross profit | 15.05B | 12.97B | 13.17B | 13.11B | 13.88B |
| Operating income | 4.11B | 1.52B | -3.84B | 1.89B | 2.85B |
| EBITDA | 5.22B | 2.67B | 3.02B | 3.07B | 4.01B |
| Net income | 2.94B | 2.94B | -3.98B | 1.02B | 1.78B |
| Basic EPS | 2.31 | 2.33 | -3.13 | 0.81 | 1.41 |
| Diluted EPS | 2.3 | 2.32 | -3.13 | 0.8 | 1.41 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 252.97B | 253.54B | 255.33B | 258.34B | 255.59B |
| Total liabilities | 175.34B | 178.16B | 182.22B | 180.79B | 178.48B |
| Total equity | 77.64B | 75.38B | 73.11B | 77.55B | 77.11B |
| Cash & equivalents | 9.54B | 8.45B | 9.1B | 11.79B | 10.08B |
| Current assets | 74.82B | 74.71B | 77.11B | 75.65B | 73.19B |
| Current liabilities | 86.41B | 88.69B | 92.7B | 94.16B | 88.96B |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 4.25B | 3.39B | 796M | 1.9B | 4.56B |
| Investing cash flow | -874M | -2B | -2.09B | -1.02B | -762M |
| Financing cash flow | -2.32B | -2.03B | -1.38B | 806M | -2.33B |
| Change in cash | 1.06B | -640M | -2.67B | 1.68B | 1.46B |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| form 4 | Form 4 — Compton-Phillips Amy | View Filing | |
| form 4 | Form 4 — Newman Brian | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | S-3ASR — CVS HEALTH Corp | View Filing | |
| edgar index | S-8 — CVS HEALTH Corp | View Filing | |
| edgar index | 144 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 144 — CVS HEALTH Corp | View Filing | |
| form 4 | Form 4 — AGUIRRE FERNANDO | View Filing | |
| form 4 | Form 4 — ROBBINS LARRY | View Filing | |
| form 4 | Form 4 — ROBBINS LARRY | View Filing | |
| form 4 | Form 4 — AGUIRRE FERNANDO | View Filing | |
| form 4 | Form 4 — ROBBINS LARRY | View Filing | |
| form 4 | Form 4 — ROBBINS LARRY | View Filing | |
| form 4 | Form 4 — ROBBINS LARRY | View Filing | |
| form 4 | Form 4 — ROBBINS LARRY | View Filing | |
| form 4 | Form 4 — ROBBINS LARRY | View Filing | |
| form 4 | Form 4 — ROBBINS LARRY | View Filing | |
| edgar index | 8-K — CVS HEALTH Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| form 4 | Form 4 — ROBBINS LARRY | View Filing | |
| form 4 | Form 4 — Shulman Douglas H. | View Filing | |
| form 4 | Form 4 — BROWN C DAVID II | View Filing | |
| form 4 | Form 4 — Finucane Anne A. | View Filing | |
| form 4 | Form 4 — DECOUDREAUX ALECIA A | View Filing | |
| form 4 | Form 4 — SANSONE GUY P | View Filing | |
| form 4 | Form 4 — Norwalk Leslie V | View Filing | |
| form 4 | Form 4 — KIRBY J SCOTT | View Filing | |
| form 4 | Form 4 — Balser Jeffrey R. | View Filing | |
| form 4 | Form 4 — AGUIRRE FERNANDO | View Filing | |
| form 4 | Form 4 — Mahoney Michael F | View Filing | |
| form 4 | Form 4 — Gallina John E | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 144 — CVS HEALTH Corp | View Filing | |
| form 4 | Form 4 — Mandadi Tilak | View Filing | |
| edgar index | 13F-HR — CVS HEALTH Corp | View Filing | |
| edgar index | 8-K — CVS HEALTH Corp | View Filing | |
| edgar index | 10-Q — CVS HEALTH Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — CVS HEALTH Corp | View Filing | |
| edgar index | DEF 14A — CVS HEALTH Corp | View Filing | |
| edgar index | DEFA14A — CVS HEALTH Corp | View Filing | |
| edgar index | ARS — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| edgar index | 4 — CVS HEALTH Corp | View Filing | |
| form 4 | Form 4 — CAPOZZI HEIDI B | View Filing | |
| form 4 | Form 4 — Clark James David | View Filing | |
| form 4 | Form 4 — Joyner J. David | View Filing | |
| form 4 | Form 4 — Khichi Samrat S. | View Filing | |
| form 4 | Form 4 — Mandadi Tilak | View Filing | |
| form 4 | Form 4 — Nelson Steven H | View Filing | |
| form 4 | Form 4 — Shah Prem S | View Filing | |
| form 4 | Form 4 — CAPOZZI HEIDI B | View Filing | |
| form 4 | Form 4 — CAPOZZI HEIDI B | View Filing |